Fluidigm Mulls Expansion into Diagnostics, Develops Higher-Density Chips

Fluidigm is developing an array for prenatal diagnosis of chromosomal abnormalities. The project, while nascent, signals that the integrated fluidic circuit maker is interested in expanding eventually beyond its activities in the research market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.